Janssen Research & Development was granted FDA orphan designation for a treatment of multiple myeloma, according to a post to the agency’s ...

Tyler Sandahl, PharmD, of Mayo Clinic, and Michael Byrne, DO, of Tennessee Oncology, discuss practical advice for bringing ...

We recently compiled a list of the 10 Best Up and Coming Stocks To Buy According to Analysts. In this article, we are going ...

Many of you may remember from this column that I have multiple myeloma, or cancer of the bone marrow. In January, I will be headed to UVA hospital for a ...

Helen van Bueren, 77, from Derbyshire, who has Multiple Myeloma, is one of those who has lost her Winter Fuel Payment and ...

Maczko said her brother died in 2016 of multiple myeloma and she had other loved ones with cancer. "We started a team years ...

There is more to the comparison, and in the sections below, we discuss why we think BMY will outperform JNJ in the next three ...

Roche inks agreement to acquire clinical-stage biopharma company, Poseida Therapeutics: Basel Wednesday, November 27, 2024, 09:00 Hrs [IST] Roche announced that it has entered int ...

Around 44,000 people with terminal illnesses will lose the payment, worth up to £300, according to figures obtained by Marie ...

Tens of thousands of terminally ill pensioners have lost their winter fuel payments ahead of what is likely to be their last ...

Intellia Therapeutics received the FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for nexiguran ziclumeran ...